XML 50 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2012
Derivative Financial Instruments [Abstract]  
Derivative Financial Instruments
(5) Derivative Financial Instruments
 
    In the normal course of business, the Company is exposed to certain risks related to fluctuations in interest rates and foreign currency exchange rates. The Company uses various derivative contracts, primarily interest rate swaps and foreign exchange forward contracts, to manage risks from these market fluctuations. The financial instruments used by the Company are straight-forward, non-leveraged instruments. The counterparties to these financial instruments are financial institutions with strong credit ratings. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit ratings of these institutions.

Interest Rate Risk
 
    The Company is exposed to changes in interest rates on its Senior Credit Facility. In order to manage this risk, on August 8, 2011, the Company entered into a four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates. The Company designated this interest rate swap as a cash flow hedge of floating rate borrowings and expects the hedge to be highly effective in offsetting fluctuations in the designated interest payments resulting from changes in the benchmark interest rate. The gains and losses on the designated swap agreement will offset losses and gains on the transactions being hedged. The Company formally documented the effectiveness of this qualifying hedge instrument (both at the inception of the swap and on an ongoing basis) in offsetting changes in cash flows of the hedged transaction. The fair value of the interest rate swap is calculated as described in Note 4, “Fair Value Measurements”, taking into consideration current interest rates and the current creditworthiness of the counterparties or the Company, as applicable.
 
    As a result of this swap, the Company pays interest at a fixed rate and receives payments at a variable rate which began on December 30, 2011. The swap effectively fixes the floating LIBOR-based interest rate to 1.25% on $250,000 of the outstanding balance under the Senior Credit Facility, with the outstanding balance subject to the swap declining over time. The interest rate swap expires on December 30, 2015. The Company will select the LIBOR-based rate on the hedged portion of the Senior Credit Facility during the term of the swap. The effective portion of the change in value of the swap is reflected as a component of comprehensive income and recognized as Interest expense, net as payments are paid or accrued. The remaining gain or loss in excess of the cumulative change in the present value of the future cash flows of the hedged item, if any (i.e., the ineffective portion) or hedge components excluded from the assessment of effectiveness are recognized as Interest expense, net during the current period.

Foreign Currency Exposures
 
    The Company is exposed to foreign currency risk related to intercompany debt and associated interest payments. To manage the risk associated with fluctuations in foreign currencies, the Company enters into foreign exchange forward contracts. The Company does not designate any of these foreign currency forward contracts as hedging instruments; however, the Company considers the contracts as economic hedges. Accordingly, changes in the fair value of these instruments affect earnings during the current period. These foreign exchange forward contracts protect against the reduction in value of forecasted foreign currency cash flows resulting from payments in foreign currencies. The fair value of foreign currency agreements are estimated as described in Note 4, “Fair Value Measurements” taking into consideration foreign currency rates and the current creditworthiness of the counterparties or the Company, as applicable.
 
    As of March 31, 2012, the Company had foreign exchange forward contracts with expiration dates ranging from April 2, 2012 through July 31, 2012. The changes in fair value of these foreign currency hedges are included as a component of Other expense, net. As of March 31, 2012, the Company had the following outstanding foreign exchange forward contracts:

Foreign Currency Denomination
 
Notional Amount
 
Japanese Yen
 
¥
45,537
 
Swedish Krone
 
kr.
1,725
 
Norwegian Krone
 
kr.
509
 
Australian Dollar
 
$
302
 
New Zealand Dollar
 
$
219
 
Singapore Dollar
 
$
100
 
United States Dollar
 
$
896
 
Swiss Franc
 
CHF
87
 
Great Britain Pound
 
£
14
 
 
    As of March 31, 2012 and December 31, 2011, the fair value carrying amount of the Company's derivative instruments included in the accompanying Condensed Consolidated Balance Sheets were recorded as follows:

 
Liability Derivatives
 
 
Balance Sheet Location
   
Fair Value
 
     
March 31, 2012
 
December 31, 2011
 
Derivatives designated as hedging instruments
               
    Interest rate swap – current
Accrued expenses and other current liabilities
 
$
1,890
 
$
1,471
 
    Interest rate swap – non-current
Other non-current liabilities
   
1,175
   
1,145
 
     
$
3,065
 
$
2,616
 
Derivatives not designated as hedging instruments
               
    Foreign exchange forward contractsAccrued expenses and other current liabilities $ - $ 935 
     
$
3,065
 
$
3,551
 
 
 
 
Asset Derivatives
 
 
Balance Sheet Location
   
Fair Value
 
     
March 31, 2012
 
December 31, 2011
 
Derivatives not designated as hedging instruments
               
    Foreign exchange forward contractsPrepaid expenses and other current assets $ 214   - 
     
$
214
 
$
-
 
 
    The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the three months ended March 31, 2012 was as follows:

Derivatives Designated as Cash Flow Hedging Relationships
   
Amount of Gain/(Loss)
Recognized in Accumulated OCL on
Derivative
(Effective Portion)
 
Location of Gain/(Loss)
Reclassified from
Accumulated OCL into
Income
(Effective Portion)
 
Amount of Gain/(Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
 
Location of Gain/(Loss)
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
 
Amount of Gain/(Loss)
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
 
Interest rate swap
 
$
(449
Interest Expense, net
 
$
(790
)
Interest Expense, net
 
$
-
 

Derivatives Not  Designated as Hedging Instruments
 
Location of Gain/(Loss)
Recognized in Income on
Derivative
 
Amount of Gain/(Loss)
Recognized in Income
on Derivative
 
Foreign exchange forward contracts
 
Other expense, net
 
$
608
 

For the three months ended March 31, 2011:

Derivatives Designated as Cash Flow Hedging Relationships
   
Amount of Gain/(Loss)
Recognized in Accumulated OCL on
Derivative
(Effective Portion)
 
Location of Gain/(Loss)
Reclassified from
Accumulated OCL into
Income
(Effective Portion)
 
Amount of Gain/(Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
 
Location of Gain/(Loss)
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
 
Amount of Gain/(Loss)
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
 
Interest rate swap
 
$
848
 
Interest Expense, net
 
$
(864
)
Interest Expense, net
 
$
-
 

Derivatives Not  Designated as Hedging Instruments
 
Location of Gain/(Loss)
Recognized in Income on
Derivative
 
Amount of Gain/(Loss)
Recognized in Income
on Derivative
 
Foreign exchange forward contracts
 
Other expense, net
 
$
1,249